Brief: 2cureX Announces Collaboration With Gibson Oncology

2cureX AB

04/04/2019 09:57

April 4 (Reuters) - 2cureX AB  2CUREX.ST :
    * 2CUREX ANNOUNCES COMMERCIAL COLLABORATION WITH GIBSON
ONCOLOGY,
USA
    * ESTABLISHED COMMERCIAL COLLABORATION WITH US BASED DRUG
DISCOVERY COMPANY GIBSON ONCOLOGY LLC
    * 2CUREX AND GIBSON ONCOLOGY ARE CURRENTLY NEGOTIATING
FINANCIAL
TERMS
    * WILL USE ITS INDITREAT TECHNOLOGY TO STRATIFY COLORECTAL
CANCER
(CRC) PATIENTS FOR SENSITIVITY TO ANTI-CANCER DRUG LMP400

Source text for Eikon:  ID:nWkr5lFngh 
Further company coverage:  2CUREX.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))